Inactief instrument

Koers Kun Run Biotechnology, Inc.

Aandelen

Duur

Periode

Stijl

KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration	17-06-10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement	22-04-10
KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results	30-03-10
KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results	13-11-09
KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million	01-04-09

Sector

	Vaira. 1 jan.	Kapi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+19,62%	43,34 mld.
OTSUKA HOLDINGS CO., LTD.	+20,44%	21,96 mld.
SANDOZ GROUP AG	+10,86%	14,09 mld.
CIPLA LIMITED	+13,07%	13,64 mld.
ZYDUS LIFESCIENCES LIMITED	+37,46%	11,43 mld.
ONO PHARMACEUTICAL CO., LTD.	-8,59%	6,86 mld.
THE MEDICINES COMPANY	-0,05%	6,79 mld.
STADA ARZNEIMITTEL	-8,87%	5,73 mld.
ASPEN PHARMACARE HOLDINGS LIMITED	+8,46%	5,22 mld.